Publications by authors named "D Carbone"

Claim this Profile
P
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer.
Dwight H Owen, Ruohan Wu, Lai Wei, Mikhail Dikov, Shankar Suman, David P Carbone

Invest New Drugs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microglial clearance, neuroprotection and cognitive recovery via a novel synthetic sulfolipid in Alzheimer's disease.
Carmela Gallo, Lucia Verrillo, Emiliano Manzo, Emma Cauzzi, Livia La Barbera, Dalila Carbone

J Neuroinflammation· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United States.
Alexander J Didier, Charlotte Lennox, Mingjia Li, Jinesh Gheeya, Asrar Alahmadi, David P Carbone

Cancer Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation.
Zhaojun Qiu, No-Joon Song, Anqi Li, Deepika Singh, Chandra B Prasad, David P Carbone

J Clin Invest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel FAK inhibitors suppress tumor growth and reverse EGFR-TKI resistance in non-small cell lung cancer.
Geng Xu, Camilla Pecoraro, Mahrou Vahabi, Dongmei Deng, Andrea Cavazzoni, Daniela Carbone

Cancer Drug Resist· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis